3M Co Liquidation Value

MMM Medical Devices

Cash & Equivalents

$3.73B
As of 2026-03-31
Current Price: $145.78 (as of 2026-04-23)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $7.46B
Total Obligations: -$20.91B
$-13.45B
Per share: $-25.79
Period: 2026-03-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $7.46B
AR: $3.75B
Total Obligations: -$20.91B
$-9.70B
Per share: $-18.59
Period: 2026-03-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $7.46B
AR: $3.75B
Inventory: $3.69B
Total Obligations: -$20.91B
$-6.01B
Per share: $-11.52
Period: 2026-03-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-13.45B$-25.79
Liquid Liquidation Value$-9.70B$-18.59
Operating Liquidation Value$-6.01B$-11.52

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-04-21. View on SEC EDGAR →

Cash & Equivalents$3.73B
Accounts Receivable$3.75B
Inventory$3.69B
Current Liabilities$9.03B
Long-term Debt (?)$10.91B
Op. Lease Liability (?)$400.00M
Finance Lease (?)N/A
Shares Outstanding521.6M

Explore all 150 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$3.73B$3.75B$3.69B$2.79B$9.03B$10.91B$400.00MN/A
2025-12-31$5.24B$3.53B$3.66B$2.70B$9.60B$10.93B$363.00MN/A
2025-09-30$4.67B$3.78B$3.89B$2.73B$8.73B$11.85B$379.00MN/A
2025-06-30$3.71B$3.76B$4.08B$2.84B$7.81B$12.48B$400.00MN/A
2025-03-31$6.33B$3.50B$3.87B$2.76B$9.45B$12.31B$415.00MN/A
2024-12-31$5.60B$3.19B$3.70B$2.66B$11.26B$11.12B$405.00M$47.00M
2024-09-30$6.05B$3.53B$4.04B$2.69B$11.39B$11.32B$443.00MN/A
2024-06-30$10.08B$3.58B$4.06B$2.81B$14.35B$11.78B$443.00MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-04-21 View
2025-12-31 10-K 2026-02-03 View
2025-09-30 10-Q 2025-10-21 View
2025-06-30 10-Q 2025-07-18 View
2025-03-31 10-Q 2025-04-22 View
2024-12-31 10-K 2025-02-05 View
2024-09-30 10-Q 2024-10-22 View
2024-06-30 10-Q 2024-07-26 View

AI Insights

AI Insight·Generated 2026-05-04

3M CO (MMM) as of March 31, 2026 presents a deeply negative liquidation posture, consistent with MFFAIS-reported CLV of negative $12.9B and OLV of negative $5.4B. Total reported assets of $35.4B are heavily weighted toward low-recovery and zero-recovery categories under liquidation haircuts. Goodwill of $6.4B and net intangibles of $1.1B ($7.5B combined) receive zero recovery. PP&E gross of $23.9B with $17.0B accumulated depreciation leaves net book value of $7.0B; at a 50-70% haircut, recoverable value is approximately $3.5-4.9B versus $7.0B carrying. Inventory of $3.7B at 60% recovery yields ~$2.2B. Accounts receivable of $3.8B (net of $45M allowance) at 90-95% recovery yields ~$3.4-3.6B. Cash and cash equivalents plus restricted cash of $3.7B recover at par; total cash and marketable securities disclosed as $4.2B. The Solventum equity stake ($1.7B fair value) is a current equity investment subject to regulatory lock-up and declining value—$356M non-cash loss on ownership change during Q1 2026 alone. On the liability side, total liabilities stand at $32.1B at face value, dominated by: long-term debt noncurrent of $10.9B, current debt of $1.7B (including $1.5B maturing in 2026), OtherLiabilitiesNoncurrent of $10.6B (which includes substantial litigation settlement obligations for PFAS/PWS and CAE matters), OtherLiabilitiesCurrent of $4.1B, and pension/OPEB noncurrent of $1.6B. The $10.6B OtherLiabilitiesNoncurrent is the single largest liability driver and encompasses multi-year legal settlement payment streams that do not extinguish on windup. AOCI is negative $5.1B, primarily reflecting cumulative pension and FX translation adjustments. Stockholders' equity of $3.3B is thin relative to the liability stack and is propped up by $38.2B retained earnings offset by $37.3B treasury stock. The company completed $2.0B in share repurchases in Q1 2026, further reducing cash from $5.9B at year-end 2025 to $4.2B. No prior filing was provided for QoQ comparison, but the cash drawdown of $1.7B in one quarter is directionally relevant to the liquidation cash buffer.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...